Cadent Therapeutics Email Format

Biotechnology ResearchMassachusetts, United States11-50 Employees

Cadent Therapeutics is a precision neuroscience company with a mission to discover and develop innovative treatments to restore brain rhythms and improve outcomes in patients living with movement, mood, and cognitive disorders. 

Currently in early clinical development, Cadent is rapidly advancing its pipeline of therapies to treat spinocerebellar ataxia, essential tremor and schizophrenia. Investors include Atlas Venture, Clal Biotechnology Industries, Slater Technology Fund. Cowen, Qiming Venture Partners, Access Industries, and Novartis. 

For more information, please visit cadenttx.com.

✕

Access Insights for Cadent Therapeutics and Millions of Other Companies

Sign up for full access to Cadent Therapeutics information.

Continue with GoogleContinue with Microsoft

No credit card needed

OR

Work email

Create AccountBy creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Sign up for free to view info

Company overview Employee directory